Funding
Northern Impact Fund 2

Northern Impact Fund 2

Key Fund

Logo shape diamond piece
Funding Available:
£5,000 to £150,000
Deadline:
ongoing

Funding Information

Providing finance to support the development or growth of trading activity, including cash-flow, working capital, and asset development or purchase.

The organisations must have clear social aims and objectives, and fit one of the following description – Not for private profit, asset locked, have clear policies/restrictions around profit distribution.

Fund Offer:

  • Investment from £5,000 to £150,000
  • Term 1 -5 years.
  • 3 product options as follows:
  • Product 1 – up to 30% of the loan amount as grant, interest rate at 6.5%, arrangement fee of 1%
  • Product 2 – up to 18% of the loan amount as grant, interest rate at 4%, arrangement fee of 1%
  • Product 3 – Shariah compliant with no interest, arrangement fee of 3.5%

Downloadable Resources

Download useful resourses
Download useful resourses
Download useful resourses

Contact Details:

Contact name:
First and Last name
Phone:
00000 000 000

See more Funding Programs

View All
This is some text inside of a div block.
Funding:
£30,000
Funding:
£30,000

Fight for Sight Digital Inclusion Fund

Grants up to £30,000 for projects that improve access to employment for blind and vision impaired people by driving digital inclusion.

This is some text inside of a div block.
Funding:
£30 million
Funding:
£30 million

Gambling Harms Prevention Fund

Funding is available for VCSE organisations for activities to prevent or reduce gambling harms, and strengthen the VCSE sector’s ability to deliver sustainable prevention activities that reach intended cohorts.

This is some text inside of a div block.
Funding:
Up to £10,000
Funding:
Up to £10,000

West Yorkshire and Harrogate Cancer Alliance’s Innovation Award 2025/26: VCSE Early Diagnosis Schemes

Funding open to VCSE organisations for events raising awareness of early signs and symptoms of cancer, practical interventions to improve early diagnosis rates and support improvements in early cancer diagnosis.